Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan Bunning

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Contemporary Clinical Trials|May 25, 2026
Micro-randomization trial design under operational constraintsBryan Bunning, Victor Ritter, Franziska K Bishop, et al.
Contemporary Clinical Trials|July 18, 2021
The COVID-19 Outpatient Pragmatic Platform Study (COPPS): Study design of a multi-center pragmatic platform trialBryan Bunning, Haley Hedlin, Natasha Purington, et al.
Journal of the American Medical Informatics Association : JAMIA|September 22, 2025
Predicting treatment retention in medication for opioid use disorder: a machine learning approach using NLP and LLM-derived clinical featuresFateme Nateghi Haredasht, Ivan Lopez, Steven Tate, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2023
Evaluation of Acebilustat, a Selective Inhibitor of Leukotriene B4 Biosynthesis, for Treatment of Outpatients With Mild-Moderate Coronavirus Disease 2019: A Randomized, Double-Blind, Placebo-Controlled Phase 2 TrialJoseph E Levitt, Haley Hedlin, Sophie Duong, et al.
Allergy|March 30, 2021
Immune changes beyond Th2 pathways during rapid multifood immunotherapy enabled with omalizumabMonali Manohar, Diane Dunham, Sheena Gupta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 21, 2022
Favipiravir for Treatment of Outpatients With Asymptomatic or Uncomplicated Coronavirus Disease 2019: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 TrialMarisa Holubar, Aruna Subramanian, Natasha Purington, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Contemporary Clinical Trials|May 25, 2026
Micro-randomization trial design under operational constraintsBryan Bunning, Victor Ritter, Franziska K Bishop, et al.
Contemporary Clinical Trials|July 18, 2021
The COVID-19 Outpatient Pragmatic Platform Study (COPPS): Study design of a multi-center pragmatic platform trialBryan Bunning, Haley Hedlin, Natasha Purington, et al.
Journal of the American Medical Informatics Association : JAMIA|September 22, 2025
Predicting treatment retention in medication for opioid use disorder: a machine learning approach using NLP and LLM-derived clinical featuresFateme Nateghi Haredasht, Ivan Lopez, Steven Tate, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2023
Evaluation of Acebilustat, a Selective Inhibitor of Leukotriene B4 Biosynthesis, for Treatment of Outpatients With Mild-Moderate Coronavirus Disease 2019: A Randomized, Double-Blind, Placebo-Controlled Phase 2 TrialJoseph E Levitt, Haley Hedlin, Sophie Duong, et al.
Allergy|March 30, 2021
Immune changes beyond Th2 pathways during rapid multifood immunotherapy enabled with omalizumabMonali Manohar, Diane Dunham, Sheena Gupta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 21, 2022
Favipiravir for Treatment of Outpatients With Asymptomatic or Uncomplicated Coronavirus Disease 2019: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 TrialMarisa Holubar, Aruna Subramanian, Natasha Purington, et al.
Pageof 2